Literature DB >> 2664428

Acute arthropod envenomation. Incidence, clinical features and management.

L S Binder1.   

Abstract

Black widow spider (Latrodectus mactans) envenomation is found throughout both the temperate and tropical latitudes, and is one of the leading causes of death from arthropod envenomations worldwide. The venom is highly neurotoxic, affecting the presynaptic motor endplate to allow massive noradrenaline (norepinephrine) and acetylcholine release into synapses causing excessive stimulation and fatigue of the motor end plate and muscle. Clinically, patients develop a bite site lesion and pain, abdominal pain and tenderness, and lower extremity pain and weakness within minutes to hours of envenomation. Symptoms progress over several hours, then subside over 2 to 3 days. The recommended treatment of 'common' envenomation is calcium gluconate 10% intravenously, titrated to relief of symptoms; antivenin, although effective, may cause hypersensitivity and serum sickness reactions, and should be restricted to life-threatening envenomations only. Brown recluse spider (Loxosceles reclusa) envenomations are seen in the Americas and in Europe, and are endemic to the south and central United States. The venom contains at least 8 enzymes, consisting of various lysins (facilitating venom spread) and sphingomyelinase D, which causes cell membrane injury and lysis, thrombosis, local ischaemia, and chemotaxis. Local envenomations begin as pain and itching that progresses to vesiculation with violaceous necrosis and surrounding erythema, and ultimately ulcer formation. Systemic envenomations may be life threatening, and present with fever, constitutional symptoms, petechial eruptions, thrombocytopenia, and haemolysis with haemoglobinuric renal failure. Treatment of local envenomations is conservative (local wound care, cryotherapy, elevation, tetanus prophylaxis, and close follow-up); systemic envenomation requires supportive care and treatment of arising complications, corticosteroids to stabilise red blood cell membranes, and support of renal function. Dapsone 100mg daily has emerged as a promising therapeutic agent in both animal studies and clinical trials. Over 650 species of scorpions are known to cause envenomation (mostly in children under 10 years); they are endemic mostly in arid and tropical areas. Different venoms and clinical presentations are seen across the different species. Most commonly, an inflammatory local reaction occurs with envenomation, which is treated with wound debridement and cleaning, tetanus prophylaxis, and antihistamines. Occasionally the venom is allergenic, and the resultant allergic reaction is treated in a standard fashion.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664428     DOI: 10.1007/bf03259994

Source DB:  PubMed          Journal:  Med Toxicol Adverse Drug Exp        ISSN: 0113-5244


  61 in total

1.  Partial characterization of the low molecular weight fractions of the extract of the venom apparatus of the brown recluse spider and of its hemolymph.

Authors:  C R Geren; T K Chan; D E Howell; G V Odell
Journal:  Toxicon       Date:  1975-08       Impact factor: 3.033

2.  Analysis of 460 fatalities from venomous animals in the United States.

Authors:  H M PARRISH
Journal:  Am J Med Sci       Date:  1963-02       Impact factor: 2.378

3.  Seasonal variation in venom of black widow spiders.

Authors:  H L KEEGAN; R A HEDEEN; F W WHITTEMORE
Journal:  Am J Trop Med Hyg       Date:  1960-09       Impact factor: 2.345

4.  Hemolytic anemia of necrotic arachnidism.

Authors:  W E NANCE
Journal:  Am J Med       Date:  1961-11       Impact factor: 4.965

5.  Toxicity from a bite of the brown spider (Loxosceles reclusus). Skin necrosis, hemolytic anemia, and hemoglobinuria in a nine-year-old child.

Authors:  G C Madrigal; R L Ercolani; J E Wenzl
Journal:  Clin Pediatr (Phila)       Date:  1972-11       Impact factor: 1.168

6.  Effect of the venom of the scorpion Tityus serrulatus on adrenal gland catecholamines.

Authors:  M C Henriques; G Gazzinelli; C R Diniz; M V Gomez
Journal:  Toxicon       Date:  1968-02       Impact factor: 3.033

7.  Necrotizing spider bites.

Authors:  P C Anderson
Journal:  Am Fam Physician       Date:  1982-09       Impact factor: 3.292

8.  Isolation and characterization of toxins from brown recluse spider venom (Loxosceles reclusa).

Authors:  C R Geren; T K Chan; D E Howell; G V Odell
Journal:  Arch Biochem Biophys       Date:  1976-05       Impact factor: 4.013

9.  Systemic effect in mice or venom apparatus extract and toxin from the brown recluse spider (Loxosceles reclusa).

Authors:  J L Babcock; R L Suber; C H Frith; C R Geren
Journal:  Toxicon       Date:  1981       Impact factor: 3.033

10.  Management of the brown recluse spider bite.

Authors:  R Rees; R B Shack; E Withers; J Madden; J Franklin; J B Lynch
Journal:  Plast Reconstr Surg       Date:  1981-11       Impact factor: 4.730

View more
  4 in total

1.  Protective effects of calcium gluconate on osteoarthritis induced by anterior cruciate ligament transection and partial medial meniscectomy in Sprague-Dawley rats.

Authors:  Su-Jin Kang; Joo-Wan Kim; Ki-Young Kim; Sae-Kwang Ku; Young-Joon Lee
Journal:  J Orthop Surg Res       Date:  2014-03-07       Impact factor: 2.359

2.  Effects of Calcium Gluconate, a Water Soluble Calcium Salt on the Collagen-Induced DBA/1J Mice Rheumatoid Arthritis.

Authors:  Ki Cheul Sohn; Su Jin Kang; Joo Wan Kim; Ki Young Kim; Sae Kwang Ku; Young Joon Lee
Journal:  Biomol Ther (Seoul)       Date:  2013-07-30       Impact factor: 4.634

Review 3.  Treatments for Latrodectism-A Systematic Review on Their Clinical Effectiveness.

Authors:  Nicole M Ryan; Nicholas A Buckley; Andis Graudins
Journal:  Toxins (Basel)       Date:  2017-04-21       Impact factor: 4.546

4.  Tick-Borne Flavivirus Inhibits Sphingomyelinase (IsSMase), a Venomous Spider Ortholog to Increase Sphingomyelin Lipid Levels for Its Survival in Ixodes scapularis Ticks.

Authors:  Pravesh Regmi; Supreet Khanal; Girish Neelakanta; Hameeda Sultana
Journal:  Front Cell Infect Microbiol       Date:  2020-06-12       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.